Stavros Moysidis, MD
Retina Specialist · Encino, CANPI 1780023929
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.3% of the total across 101 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 23.3% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for retina specialist clinicians in CA, where the typical reported total is $3,667.
Across 101 payments — averaging $37.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$880
- AbbVie$485
- Genentech USA, Inc.$409
- Apellis Pharmaceuticals, Inc.$294
- Novartis$217
- Glaukos Corporation$207
- plus $1K from 17 others
What the payments were for
- Food & beverage$3,66997%
- Gifts$391%
- Entertainment$642%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 25 | $880 |
| AbbVie(2 entities) | 21 | $485 |
| Genentech USA, Inc. | 12 | $409 |
| Apellis Pharmaceuticals, Inc. | 6 | $294 |
| Novartis | 2 | $217 |
| Glaukos Corporation | 1 | $207 |
| Alcon | 2 | $186 |
| Alimera Sciences, Inc. | 10 | $184 |
| Astellas Pharma US Inc | 5 | $130 |
| Regeneron | 1 | $125 |
| Aerie Pharmaceuticals, Inc. | 1 | $125 |
| Genentech, Inc. | 1 | $111 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $107 |
| Optos, Inc. | 2 | $64 |
| Eyepoint US, Inc. | 2 | $39 |
| Carl Zeiss Meditec AG | 2 | $39 |
| Carl Zeiss Meditec USA, Inc. | 1 | $39 |
| ANI Pharmaceuticals, Inc. | 1 | $29 |
| LKC Technologies, Inc. | 1 | $28 |
| Thea Pharma Inc. | 1 | $24 |
| Bausch & Lomb Americas Inc. | 1 | $22 |
| Spark Therapeutics, Inc. | 1 | $16 |
| Dutch Ophthalmic, USA | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EYLEA$477
- Lucentis$236
- iDoseTR$207
- VABYSMO$125
- Rhopressa$125
- Rocklatan$125
- Syfovre$124
- ARGOS$118
- Non-Covered Product$111
- Tecnis Symfony IOL$107
How this compares
$3,773 in reported general payments places this provider in the 50th percentile of 187 retina specialist providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ProlensaBromfenac Sodium | 48 | $26,204 |
| Bromfenac Sodium | 25 | $5,357 |
| Prednisolone Acetate | 97 | $4,034 |
| ErythromycinErythromycin Base | 16 | $1,425 |
| Atropine Sulfate | 38 | $1,052 |
| Ketorolac Tromethamine | 26 | $468 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 26 | $415 |
| Ofloxacin | 45 | $389 |
| Latanoprost | 34 | $197 |
| Timolol Maleate | 13 | $172 |
| Brimonidine Tartrate | 18 | $155 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Encino
- Jessica CaoEncino$11K
- Dilsher DhootSanta Barbara$1.9M
- Ehsan RahimyStanford$1.5M
- Darius MoshfeghiPalo Alto$1.4M
- Nathan SteinleSanta Barbara$1.1M
- Roger GoldbergWalnut Creek$1.1M
- Baruch KuppermannIrvine$1M
- Carlos Medina MendezSacramento$548K
- Michael JavaheriBeverly Hills$540K
- Esther KimSanta Ana$367K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.